4161:TADAWULBinDawood Holding Company Analysis
Data as of 2026-05-26 - not real-time
₩32,200.00
Latest Price
8/10Risk
Risk Level: High
Executive Summary
The stock is trading below its short‑ and medium‑term moving averages, and the MACD is generating a bearish signal, suggesting continued downside pressure. RSI sits in a neutral zone while volume has been trending lower, reinforcing the lack of buying momentum. The high beta and elevated 30‑day volatility point to pronounced market sensitivity and price swings.
Fundamentally, the company shows solid top‑line growth but struggles with negative operating margins and cash flow deficits, while debt levels dwarf its equity base. The dividend yield appears attractive but the payout ratio far exceeds earnings, making the payout unsustainable. Combined with a price‑to‑sales multiple that outpaces peers and an absence of meaningful earnings, the valuation leans toward overvaluation despite the price being below recent averages.
Fundamentally, the company shows solid top‑line growth but struggles with negative operating margins and cash flow deficits, while debt levels dwarf its equity base. The dividend yield appears attractive but the payout ratio far exceeds earnings, making the payout unsustainable. Combined with a price‑to‑sales multiple that outpaces peers and an absence of meaningful earnings, the valuation leans toward overvaluation despite the price being below recent averages.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Bearish technical indicators (price below SMAs, negative MACD)
- Decreasing volume indicating weak liquidity
- High leverage and negative cash flow
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Strong revenue growth potential in EV and battery segments
- Ongoing profitability challenges and debt load
- Unsustainable dividend raising capital concerns
Long Term
> 3 yearsNeutral
Model confidence: 4/10
Key Factors
- Long‑term secular tailwinds for electric‑vehicle components
- Need for significant balance‑sheet restructuring
- Uncertainty around achieving consistent earnings
Key Metrics & Analysis
Financial Health
Revenue Growth21.50%
Profit Margin0.47%
ROE0.54%
ROA0.73%
Debt/Equity108.30
Op. Cash Flow₩-8590059520
Free Cash Flow₩-64916754432
Industry P/E29.7
Technical Analysis
TrendNeutral
RSI42.4
Support₩28,200.00
Resistance₩39,800.00
MA 20₩34,965.00
MA 50₩34,888.00
MA 200₩37,144.25
MACDBearish
VolumeDecreasing
Fear & Greed Index91.43
Valuation
GradeOvervalued
TypeBlend
Dividend Yield0.62%
Risk Assessment
Beta1.70
Volatility52.93%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.